Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aratana Therapeutics Inc Announces Pricing Of Initial Public Offering


Thursday, 27 Jun 2013 07:00am EDT 

Aratana Therapeutics Inc announced the pricing of its initial public offering of 5,750,000 shares of its common stock at a price of $6.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on June 27, 2013 under the ticker symbol 'PETX.' All of the common stock is being offered by Aratana Therapeutics. In addition, Aratana Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 862,500 shares of common stock to cover over-allotments, if any, at the initial public offering price. Stifel and Lazard Capital Markets are acting as lead book-running managers for the offering. William Blair, JMP Securities and Craig-Hallum Capital Group are acting as co-managers. 

Company Quote

9.59
-0.45 -4.48%
1 Oct 2014